BerandaCYBN • NYSEAMERICAN
add
Cybin Inc
$6,66
Setelah Jam Perdagangan Normal:(1,49%)-0,099
$6,56
Tutup: 15 Des, 18.34.40 GMT-5 · USD · NYSEAMERICAN · Pernyataan Penyangkalan
Tutup sebelumnya
$6,68
Rentang hari
$6,56 - $7,06
Rentang tahun
$4,81 - $10,73
Volume Rata-Rata
730,74Â rb
Rasio P/E
-
Hasil dividen
-
Dalam berita
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | — | — |
Biaya operasional | 28,89Â jt | -32,34% |
Penghasilan bersih | -33,72Â jt | 19,57% |
Margin laba bersih | — | — |
Penghasilan per saham | -1,65 | 42,14% |
EBITDA | -28,86Â jt | 32,24% |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 83,75Â jt | -26,68% |
Total aset | 181,25Â jt | -6,68% |
Total liabilitas | 42,25Â jt | 674,14% |
Total ekuitas | 139,00 jt | — |
Saham yang beredar | 49,89 jt | — |
Harga terhadap nilai buku | 1,25 | — |
Tingkat pengembalian aset | -36,85% | — |
Tingkat pengembalian modal | -39,67% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | -33,72Â jt | 19,57% |
Kas dari operasi | -34,48Â jt | -80,42% |
Kas dari investasi | -436,00Â rb | -73,71% |
Kas dari pembiayaan | 27,00Â rb | 109,96% |
Perubahan kas bersih | -34,94Â jt | -78,39% |
Arus kas bebas | -25,15Â jt | -349,27% |
Tentang
Cybin IRL is a Canadian pharmaceutical company that is developing psychedelic drugs as medicines.
The company's drug candidates include psilocybin, CYB002, CYB003, CYB004, CYB005, and CYB006. Another drug that the company has developed is CYB210010.
As of January 2025, CYB003 is in phase 3 clinical trials. The drug is one of the only other psychedelics besides Compass Pathways's COMP360 to have reached this late stage of clinical development.
In 2020, Cybin acquired psychedelic pharmaceutical company Adelia Therapeutics. Wikipedia
Didirikan
2019
Kantor pusat
Situs
Karyawan
50
